2 results match your criteria: "Research Institute PLIVA[Affiliation]"
Hepatogastroenterology
February 2007
Research Institute PLIVA, Department of Pharmacology and Medicinal Safety, Zagreb, Croatia.
Background/aims: To evaluate the expression of antigens c-erbB-2, p53, and Ki-67 in gastric biopsy, bacteria density and urease activity in two groups of patients with chronic gastritis separated on the basis of the success or failure of H. pylori eradication.
Methodology: Sixty-five patients with chronic gastritis were split in two groups (n=45/20) related to response to the therapy.
Arzneimittelforschung
August 1997
Biomedical Department, Research Institute PLIVA, Zagreb, Republic of Croatia.
The effect of chronic treatment with the non-selective beta-blocker oxprenolol (CAS 6452-71-7) administered orally in two different doses (15 or 30 mg/kg/day for 6, 10 and 12 weeks) on plasma cholinesterase (PChE) activity and on the plasma level of triglyceride and total cholesterol were studied in normal rats. In all treated groups a significant increase (approximately 27-51%) of PChE activity was obtained (p < 0.05 vs.
View Article and Find Full Text PDF